主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ADIL
#4023
Adial Pharmaceuticals, Inc
2.5
3
+3.27%
版块:
基础:
利润货币:
日范围
年范围
日变化
+3.27%
每月变动
+1000.00%
6个月变化
+548.72%
年变化
+232.89%
前一天收盘价
2.4
5
Open
2.5
3
Bid
Ask
Low
2.5
3
High
2.5
3
交易量
1
市场
股票
医疗保健
ADIL
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
27.63 K
37.95 K
45.63 K
162.19 K
262.98 K
—
Valuation ratios
Enterprise value
—
—
—
-2.54 M
-3.48 M
-15.57 M
Price to earnings ratio
—
—
—
-0.02
-0.01
-0.16
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
-0.01
-0.03
-0.07
Price to book ratio
—
—
—
0.02
0.05
0.07
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
1.98
-2.6
-2.22
-1.08
-2.62
-1.66
Return on equity %
2.73
-5.54
-3.89
-1.25
-3.24
-2.31
Return on invested capital %
12.16 K
-10.75 K
-4 697.79
-1 964.47
-2 507.23
—
Gross margin %
100
100
—
—
—
—
Operating margin %
2 906.38
-41.49 K
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
2 897.07
-41.78 K
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
4.2
3.69
—
Current ratio
3.41
2.37
2.67
4.9
4.16
15.51
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.06
0.01
0
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
0.01
—
—
—
Long term debt to total equity ratio
—
0.01
0.01
—
—
—
Per share metrics
Operating cash flow per share
—
—
-279.23
-119.45
-35.67
-19.74
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
99.89
49.61
19.33
47.49
Net current asset value per share
—
—
119.32
56.13
20.92
50.93
Tangible book value per share
—
—
75.46
71.59
20.95
47.29
Working capital per share
—
—
74.61
44.67
15.89
36.68
Book value per share
—
—
81.79
71.66
20.96
47.33
新闻
FDA政策转变推动Adial Pharmaceuticals股价上涨
Adial Pharmaceuticals stock rises on FDA policy shift
Adial Pharmaceuticals寻求通过单一关键性试验推进AD04项目
Adial Pharmaceuticals eyes single pivotal trial path for AD04
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories! - TipRanks.com
Adial制药公司宣布1比25反向拆股后股价暴跌
Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split
Adial制药公司宣布1比25反向拆股
Adial Pharmaceuticals announces 1-for-25 reverse stock split
Adial制药公司宣布董事会成员James W. Newman, Jr.辞职
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr.
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?